32176 Federal Register / Vol. 87, No. 103 / Friday, May 27, 2022 / Notices 

requests for information on highly 

technical matters and matters of 

scientific and public policy related to 

health resources and policy. 

Systems Technology Office (NYC, 

formerly HNYC). (1) Focuses on those 

systems that impact health—from 

physiologic systems (e.g., immune) to 

the healthcare system and everything in 

between. (2) Speeds progress in the 

integration of systems, including and 

especially technological approaches to 

doing so. (3) Advises the ARPA–H 

Director on matters concerning ARPA– 

H-sponsored research activities related 

to health systems technology. (4) 

Responds to requests for information on 

highly technical matters and matters of 

scientific and public policy related to 

health systems technology. 

Equity and Inclusion Office (NYD, 

formerly HNYD). (1) Coordinates, 

facilitates, and supports programs to 

ensure equity, diversity, and inclusion 

in all aspects of ARPA–H’s work. (2) 

Provides strategic and programmatic 

leadership for ARPA–H’s efforts to 

reduce health disparities and foster 

health equity in biomedical research. (3) 

Evaluates ARPA–H’s progress towards 

achieving greater diversity and health 

equity in biomedical and health 

research. (4) Promotes ARPA–H efforts 

to build a diverse cohort of 

collaborators, staff, performers, and 

others. 

Strategic Planning, Evaluation, and 

Analytics Office (NYE, formerly HNYE). 

(1) Oversees ARPA–H-wide planning, 

evaluation, and analysis/analytic 

activities. (2) Advises ARPA–H 

leadership and staff on all aspects of 

strategic planning, reporting, and 

operational effectiveness for ARPA–H 

activities. (3) Provides leadership and 

guidance to ARPA–H’s business 

community in the development and 

oversight of a strategic administrative 

management plan, goals, organizational 

effectiveness and business analytics. (4) 

Oversees the development of analytic 

and evaluation strategies to drive greater 

efficiency and effectiveness in 

administrative and programmatic 

operations. 

Innovation and Entrepreneurship 

Office (NYF, formerly HNYF). (1) 

Inspires innovation and creativity 

throughout ARPA–H, including 

stimulating the culture of innovation, 

ideation, and dynamic thinking and 

leveraging design research and design 

thinking. (2) Promotes practical 

strategies to provide resources for 

programs and projects to incorporate 

and implement transition principles to 

inform innovation in overall ARPA–H 

commercialization strategies. (3) Serves 

as the ARPA–H focal point for the 

management of all Small Business 

Innovation Research (SBIR) and Small 

Business Technology Transfer (STTR) 

Program activities, and implementation 

of pertinent legislation, rules and 

regulations and associated matters 

related to the SBIR/STTR Program. (4) 

Proposes and implements innovative 

strategies to promote the 

commercialization of innovative high 

impact technologies including research 

tools, medical devices, and therapeutics 

throughout the program development 

and management lifecycle. (5) Assesses 

the commercial potential of ARPA–H 

technology priorities and provides 

guidance on how best to structure 

programs, projects, and goals for 

successful transition. 

Delegations of Authority: All 

delegations and redelegations of 

authority to officers and employees of 

NIH that were in effect immediately 

prior to the effective date of this 

amendment and are consistent with this 

amendment shall continue in effect, 

pending further redelegation. 

Dated: May 24, 2022. 

Xavier Becerra, 

Secretary, U.S. Department of Health and 

Human Services. 

[FR Doc. 2022–11519 Filed 5–25–22; 4:15 pm] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the Frederick National 

Laboratory Advisory Committee to the 

National Cancer Institute. 

The meeting will be held virtually 

and is open to the public. Individuals 

who plan to view the virtual meeting 

and need special assistance or other 

reasonable accommodations to view the 

meeting, should notify the Contact 

Person listed below in advance of the 

meeting. The meeting will be videocast 

and can be accessed from the NIH 

Videocasting and Podcasting website 

(http://videocast.nih.gov). 

Name of Committee: Frederick National 

Laboratory Advisory Committee to the 

National Cancer Institute. 

Date: June 27, 2022. 

Time: 11:00 a.m. to 2:00 p.m. 

Agenda: Ongoing and new activities at the 

Frederick National Laboratory for Cancer 

Research. 

Place: National Cancer Institute Shady 

Grove, 9609 Medical Center Drive, Rockville, 

MD 20850 (Virtual Meeting). 

Contact Person: Wlodek Lopaczynski, 

M.D., Ph.D., Assistant Director, Office of the 

Director, Division of Extramural Activities, 

National Cancer Institute, National Institutes 

of Health, 9609 Medical Center Drive, 

Seventh Floor, West Tower, Room 7W514, 

Bethesda, MD 20892, (240) 276–6458, 

lopacw@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: FNLAC: 

https://deainfo.nci.nih.gov/advisory/fac/ 

fac.htm, where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: May 24, 2022. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–11458 Filed 5–26–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Human Genome Research 

Institute; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Inherited 

Disease Research Access Committee. 

Date: July 8, 2022. 

Time: 11:30 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 


jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 103 / Friday, May 27, 2022 / Notices 32177 

Place: National Human Genome Research 

Institute, National Institutes of Health, 6700B 

Rockledge Drive, Suite 300, Bethesda, MD 

20892 (Virtual Meeting). 

Contact Person: Barbara J. Thomas, Ph.D., 

Scientific Review Officer, National Human 

Genome Research Institute, National 

Institutes of Health, 6700B Rockledge Drive, 

Suite 300, Bethesda, MD 20892, 301–402– 

8837, barbara.thomas@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.172, Human Genome 

Research, National Institutes of Health, HHS) 

Dated: May 24, 2022. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–11453 Filed 5–26–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; 

Optimizing Digital Mental Health 

Interventions (R01). 

Date: June 22, 2022. 

Time: 11:00 a.m. to 1:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Virtual 

Meeting). 

Contact Person: Erin E. Gray, Ph.D., 

Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, National Institutes of Health, 

6001 Executive Boulevard NSC 6152B, 

Bethesda, MD 20892, 301–402–8152, 

erin.gray@nih.gov. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; NonPharmacological Clinical Trials. 

Date: June 23, 2022. 

Time: 12:00 p.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Virtual 

Meeting). 

Contact Person: Regina Dolan-Sewell, 

Ph.D., Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, National Institutes of Health, 

Neuroscience Center, 6001 Executive BLVD, 

Room 4154, MSC 9606, Bethesda, MD 20852, 

regina.dolan-sewell@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program No. 93.242, Mental Health Research 

Grants, National Institutes of Health, HHS) 

Dated: May 24, 2022. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–11454 Filed 5–26–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Cancer 

Advisory Board and NCI Board of 

Scientific Advisors. 

The meeting will be held as a virtual 

meeting and is open to the public as 

indicated below. Individuals who plan 

to view the virtual meeting and need 

special assistance or other reasonable 

accommodations to view the meeting 

should notify the Contact Person listed 

below in advance of the meeting. The 

meeting will be videocast and can be 

accessed from the NIH Videocasting and 

Podcasting website (http://

videocast.nih.gov/). 

A portion of the National Cancer 

Advisory Board meeting will be closed 

to the public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Advisory Board and NCI Board of Scientific 

Advisors. 

Date: June 13, 2022. 

Open: 1:00 p.m. to 4:00 p.m. 

Agenda: NCAB Subcommittee Meetings. 

Place: National Cancer Institute—Shady 

Grove, 9609 Medical Center Drive, Rockville, 

MD 20850 (Virtual Meeting). 

Name of Committee: National Cancer 

Advisory Board and NCI Board of Scientific 

Advisors. 

Date: June 14, 2022. 

Open: 12:00 p.m. to 3:30 p.m. 

Agenda: Joint meeting of the National 

Cancer Advisory Board and NCI Board of 

Scientific Advisors, NCI Acting Director’s 

Report and Presentations. 

Closed: 4:00 p.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute—Shady 

Grove, 9609 Medical Center Drive, Rockville, 

MD 20850 (Virtual Meeting). 

Name of Committee: National Cancer 

Advisory Board and NCI Board of Scientific 

Advisors. 

Date: June 15, 2022. 

Open: 1:00 p.m. to 6:00 p.m. 

Agenda: Joint meeting of the National 

Cancer Advisory Board and NCI Board of 

Scientific Advisors, NCI Board of Scientific 

Advisors Concepts Review and Presentations. 

Place: National Cancer Institute—Shady 

Grove, 9609 Medical Center Drive, Rockville, 

MD 20850 (Virtual Meeting). 

Contact Person: Paulette S. Gray, Ph.D., 

Director, Division of Extramural Activities, 

National Cancer Institute—Shady Grove, 

National Institutes of Health, 9609 Medical 

Center Drive, 7th Floor, Room. 7W444, 

Bethesda, MD 20892, 240–276–6340, grayp@

mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: NCAB: 

https://deainfo.nci.nih.gov/advisory/ncab/ 

ncabmeetings.htm, BSA: https://

deainfo.nci.nih.gov/advisory/bsa/ 

bsameetings.htm, where an agenda and any 

additional information for the meeting will 

be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: May 24, 2022. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–11457 Filed 5–26–22; 8:45 am] 

BILLING CODE 4140–01–P 


jspears on DSK121TN23PROD with NOTICES1